These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 23032938)

  • 21. Development of a fluorescent-tagged kinase assay system for the detection and characterization of allosteric kinase inhibitors.
    Simard JR; Getlik M; Grütter C; Pawar V; Wulfert S; Rabiller M; Rauh D
    J Am Chem Soc; 2009 Sep; 131(37):13286-96. PubMed ID: 19572644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-based design, synthesis, and study of pyrazolo[1,5-a][1,3,5]triazine derivatives as potent inhibitors of protein kinase CK2.
    Nie Z; Perretta C; Erickson P; Margosiak S; Almassy R; Lu J; Averill A; Yager KM; Chu S
    Bioorg Med Chem Lett; 2007 Aug; 17(15):4191-5. PubMed ID: 17540560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thiazole- and selenazole-comprising high-affinity inhibitors possess bright microsecond-scale photoluminescence in complex with protein kinase CK2.
    Vahter J; Viht K; Uri A; Manoharan GB; Enkvist E
    Bioorg Med Chem; 2018 Oct; 26(18):5062-5068. PubMed ID: 30217463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The CK2 alpha/CK2 beta interface of human protein kinase CK2 harbors a binding pocket for small molecules.
    Raaf J; Brunstein E; Issinger OG; Niefind K
    Chem Biol; 2008 Feb; 15(2):111-7. PubMed ID: 18291315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biological properties and structural study of new aminoalkyl derivatives of benzimidazole and benzotriazole, dual inhibitors of CK2 and PIM1 kinases.
    Chojnacki K; Wińska P; Wielechowska M; Łukowska-Chojnacka E; Tölzer C; Niefind K; Bretner M
    Bioorg Chem; 2018 Oct; 80():266-275. PubMed ID: 29966873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of polyoxometalates as nanomolar noncompetitive inhibitors of protein kinase CK2.
    Prudent R; Moucadel V; Laudet B; Barette C; Lafanechère L; Hasenknopf B; Li J; Bareyt S; Lacôte E; Thorimbert S; Malacria M; Gouzerh P; Cochet C
    Chem Biol; 2008 Jul; 15(7):683-92. PubMed ID: 18635005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 2-Dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole: a novel powerful and selective inhibitor of protein kinase CK2.
    Pagano MA; Meggio F; Ruzzene M; Andrzejewska M; Kazimierczuk Z; Pinna LA
    Biochem Biophys Res Commun; 2004 Sep; 321(4):1040-4. PubMed ID: 15358133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-affinity bisubstrate probe for fluorescence anisotropy binding/displacement assays with protein kinases PKA and ROCK.
    Vaasa A; Viil I; Enkvist E; Viht K; Raidaru G; Lavogina D; Uri A
    Anal Biochem; 2009 Feb; 385(1):85-93. PubMed ID: 19017524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The protein kinase CK2(Andante) holoenzyme structure supports proposed models of autoregulation and trans-autophosphorylation.
    Schnitzler A; Olsen BB; Issinger OG; Niefind K
    J Mol Biol; 2014 May; 426(9):1871-82. PubMed ID: 24594356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a high-throughput screening-compatible assay to identify inhibitors of the CK2α/CK2β interaction.
    Hochscherf J; Lindenblatt D; Steinkrüger M; Yoo E; Ulucan Ö; Herzig S; Issinger OG; Helms V; Götz C; Neundorf I; Niefind K; Pietsch M
    Anal Biochem; 2015 Jan; 468():4-14. PubMed ID: 25233003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-based Discovery of Novel CK2α-Binding Cyclic Peptides with Anti-cancer Activity.
    Tang S; Zhang N; Zhou Y; Cortopassi WA; Jacobson MP; Zhao LJ; Zhong RG
    Mol Inform; 2019 Mar; 38(3):e1800089. PubMed ID: 30307134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
    Izeradjene K; Douglas L; Delaney A; Houghton JA
    Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis of novel polybrominated benzimidazole derivatives-potential CK2 inhibitors with anticancer and proapoptotic activity.
    Łukowska-Chojnacka E; Wińska P; Wielechowska M; Poprzeczko M; Bretner M
    Bioorg Med Chem; 2016 Feb; 24(4):735-41. PubMed ID: 26778657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acetoxymethyl Ester of Tetrabromobenzimidazole-Peptoid Conjugate for Inhibition of Protein Kinase CK2 in Living Cells.
    Viht K; Saaver S; Vahter J; Enkvist E; Lavogina D; Sinijärv H; Raidaru G; Guerra B; Issinger OG; Uri A
    Bioconjug Chem; 2015 Dec; 26(12):2324-35. PubMed ID: 26559659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A CE-based assay for human protein kinase CK2 activity measurement and inhibitor screening.
    Gratz A; Götz C; Jose J
    Electrophoresis; 2010 Jan; 31(4):634-40. PubMed ID: 20162588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure of the human protein kinase CK2 catalytic subunit CK2α' and interaction thermodynamics with the regulatory subunit CK2β.
    Bischoff N; Olsen B; Raaf J; Bretner M; Issinger OG; Niefind K
    J Mol Biol; 2011 Mar; 407(1):1-12. PubMed ID: 21241709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and biological evaluation of novel substituted pyrrolo[1,2-a]quinoxaline derivatives as inhibitors of the human protein kinase CK2.
    Guillon J; Le Borgne M; Rimbault C; Moreau S; Savrimoutou S; Pinaud N; Baratin S; Marchivie M; Roche S; Bollacke A; Pecci A; Alvarez L; Desplat V; Jose J
    Eur J Med Chem; 2013 Jul; 65():205-22. PubMed ID: 23711832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benzimidazole inhibitors of protein kinase CK2 potently inhibit the activity of atypical protein kinase Rio1.
    Kubiński K; Masłyk M; Orzeszko A
    Mol Cell Biochem; 2017 Feb; 426(1-2):195-203. PubMed ID: 27909846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and exploitation of CK2 inhibitors.
    Sarno S; Ruzzene M; Frascella P; Pagano MA; Meggio F; Zambon A; Mazzorana M; Di Maira G; Lucchini V; Pinna LA
    Mol Cell Biochem; 2005 Jun; 274(1-2):69-76. PubMed ID: 16335530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and biological evaluation of substituted (thieno[2,3-d]pyrimidin-4-ylthio)carboxylic acids as inhibitors of human protein kinase CK2.
    Golub AG; Bdzhola VG; Briukhovetska NV; Balanda AO; Kukharenko OP; Kotey IM; Ostrynska OV; Yarmoluk SM
    Eur J Med Chem; 2011 Mar; 46(3):870-6. PubMed ID: 21276643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.